Average Co-Inventor Count = 4.69
ph-index = 1
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Glaxosmithkline Istrazivacki Centar Zagreb D.o.o. (2 from 8 patents)
2. Pliva-istrazivacki Institut D.o.o. (2 from 4 patents)
3. Glaxosmithkline LLC (1 from 356 patents)
4. Glaxosmithkline Istrazivacki Center Zagreb D.o.o (1 from 2 patents)
5. Fidelta D.o.o. (1 from 1 patent)
6. Selvita D.o.o. (1 from 1 patent)
7. Glaxosmithkline Istraziva{hacek Over (c)}ki Centar Zagreb D.o.o. (1 from 1 patent)
8. Glaxosmith Kline Istrazivocki Centar Zagreb, D.o.o. (1 from 1 patent)
10 patents:
1. 11512096 - Seco macrolide compounds
2. 10919910 - Seco macrolide compounds
3. 7550498 - 1,2-Diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
4. 7435834 - 2-thia-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
5. 7312203 - 1-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
6. 7262309 - 1- or 3-thia-benzonaphthoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof
7. 7262302 - 1-thia-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
8. 7232815 - 1-oxa-3-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the production thereof
9. 7166583 - 1,3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
10. 6897211 - Thienodibenzoazulene compounds as tumor necrosis factor inhibitors